Beclometasone/ formoterol/ glycopyrronium pMDI for maintenance treatment of moderate to severe COPD

Description

In this Product Explainer, Dr Philip Lee explains the role of beclomethasone/ formoterol/ glycopyrronium pressurised metered dose inhalers (pMDIs) for maintenance treatment of adults with moderate to severe COPD who are not adequately treated by ICS/LABA or LABA/LAMA (7 mins).

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
Dr Chrys Pulle

Dr Chrys Pulle

Practical Strategies for Behaviour Management in Dementia

A/Prof Michael Woodward AM

A/Prof Michael Woodward AM

The New Pneumococcal Vaccination for Older Adults – What You Need to Know

Prof Rodney Baber AM

Prof Rodney Baber AM

Adolescent Contraception – Common Myths

Dr Jo-Ann See

Dr Jo-Ann See

Acne Practical Cases – Trunk, Skin of Colour

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Dr Philip Lee

expert

Dr Philip Lee

Respiratory and Sleep Physician; Consultant, Respiratory and Sleep Medicine, St George and Northern Beaches Hospitals

Date published: 14 August 2024